Please read MedicalResearch.com Interview Mario Mandalà, MD concerning his research on PD-L1 As Negative Prognostic Marker for melanoma
MRV Research
Melanoma risk found to have genetic determinant
A leading Dartmouth researcher, working with The Melanoma Genetics Consortium, GenoMEL, an international research consortium, co-authored a paper published today in the Journal of the National Cancer Institute that proves longer telomeres increase the risk of melanoma.
Fresh Approaches for Treating Micro-Metastatic Melanoma Explored
Approximately 85% of patients with newly diagnosed melanoma present with what appears to be clinically localized disease, making them candidates for standard treatment with surgery. But some of these patients may be harboring microscopic metastases in their lymph nodes
Chromosome buffers hold key to better melanoma understanding
Buffers that guard against damage to the ends of chromosomes could hold the key to a better understanding of malignant melanoma – the deadliest form of skin cancer – according to new research from the University of Leeds.